An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

Lenny Santoro was diagnosed with prostate cancer in 2011. Thanks to clinical trials Santoro participated in at the Duke ...

French biotechnology company MaaT Pharma has reported positive results from an interim safety analysis of its Phase IIb ...

UVA professor Dr. Christopher Kramer explains how a new Eli Lilly drug may cut a significant heart attack risk factor by 95%.

Heart disease experts are hailing the results of a clinical trial showed a strongly positive performance by a drug that ...

Bureaucracy and delays are pushing clinical trials away from Europe, with Asia and the United States taking the lead.

IGC Pharma (IGC) announced the expansion of its ongoing Phase 2 CALMA clinical trial with the addition of Butler Hospital’s Memory and Aging ...

The National Cancer Institute’s Investigational New Drug program facilitates collaboration, not collusion, with industry for ...

The IQVIA Institute for Human Data Science has released, Global Trends in R&D 2025 report, Progress in Recapturing Momentum ...

Edgewise Therapeutics shares tumbled more than 20% Wednesday after the developmental drug company issued the results of its ...

If the drug passes all its trials and at some point ... cocaine use in patients with cocaine use disorder in a phase 2 clinical trial, Science Translational Medicine (2025). DOI: 10.1126 ...